Dr. Mark L. Barba, MD

Dr. Barba practices at Orthomidwest in Rockford, Illinois.

Dr. Barba's NPI, 1730292400, was assigned on August 16, 2006. Dr. Barba graduated from University of Illinois College of Medicine - Chicago in 1991. Dr. Barba holds Illinois license 036-093362.

Dr. Barba's primary practice is Orthomidwest, at 324 Roxbury Rd, Rockford, IL 61107 in Winnebago County. The practice phone is (815) 398-9491.

Dr. Barba's primary practice is Orthomidwest in Rockford, Illinois. Dr. Barba is also affiliated with UW Health SwedishAmerican Hospital. The medical group on file is OrthoIllinois. Dmand AI also links Dr. Barba to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barba practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Barba's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Barba is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Barba's licenses on file in 3 states: Illinois, Wisconsin and Michigan.

Dmand AI lists arthritis, bursitis, hip replacement, joint pain, knee arthroscopy, knee replacement, lower back pain and pelvic and hip fracture among the conditions Dr. Barba treats.

CMS data shows 1,731 Medicare services from Dr. Barba across 14 procedure codes in 2024, for 419 Medicare patients. Medicare paid $131,422 for them.

CMS counts 419 Medicare patients who saw Dr. Barba in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have arthritis, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Barba's median patient age at 71, with 61% women.

In 2024, Dr. Barba wrote 444 Medicare Part D claims for 210 patients. 100% of them were for generic drugs. CMS names the drug for 389 of them, across 4 drugs with 11 or more claims each, at $377 in total drug cost. In 2023, CMS named 409 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Barba for performance year 2024, reported as part of a group. Dr. Barba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barba as offering telehealth. CMS counts 35 procedures of hip replacement by Dr. Barba, more than 80% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Barba, published from 2017 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Hip Prosthesis, Arthroplasty, Replacement, Hip and Corrosion. Dr. Barba has published most often in J Mech Behav Biomed Mater. Dr. Barba's most frequent co-author is Harold Wharton Rees, MD.

CMS Open Payments shows 107 general payments to Dr. Barba from 9 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 82% of the total. Zimmer Biomet Holdings, Inc. paid the most, $9,229. It also lists 2 research payments totaling $1,611 in 2016.

Dmand AI lists 2 awards for Dr. Barba, most recently CMS Stage 1 EHR in 2013.

Dr. Barba graduated from University of Illinois College of Medicine - Chicago in 1991. Dr. Barba is a member of AAOS.

Dr. Barba is in network with 18 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.